Form 4: BioAtla Director Eddie Williams Acquires 16,500 Shares of Common Stock

Director Eddie Williams acquired 16,500 shares of BioAtla, Inc. common stock on June 13, 2024, through a restricted stock unit award.

Summary

• On June 13, 2024, Eddie Williams, a director of BioAtla, Inc., acquired 16,500 shares of common stock.
• The acquisition was made through a time-based restricted stock unit (RSU) award.
• The RSU will vest as to 100% of the total number of shares on the earlier of June 13, 2025, or the next Company annual meeting of stockholders, contingent upon continued service.
• Following the transaction, Williams directly owns 36,700 shares of BioAtla common stock.

Sentiment

Score: 6

Explanation: The sentiment is neutral. It's a standard disclosure of stock acquisition by a director, which can be seen as a slightly positive sign of confidence, but it's not a major event.

Positives

• A director's acquisition of shares can be seen as a positive signal, indicating confidence in the company's future prospects.

Future Outlook

The vesting of the RSU is contingent upon the director's continued service, aligning their interests with the company's long-term performance.

Industry Context

Form 4 filings are routine disclosures of insider transactions, providing transparency to the market regarding the buying and selling activities of company insiders.

Stakeholder Impact

• The transaction provides transparency to shareholders regarding insider activity.
• The vesting of the RSU incentivizes the director to remain with the company and contribute to its success.

Key Dates